Robert Chu and Richie Etwaru tell Craig Sharp that pharma has to orchestrate a truly integrated effort from sales and marketing teams to attain commercial effectiveness.
The EMA's human medicines committee has recommended against approval of Eisai and Biogen's Alzheimer's disease therapy Leqembi, after regulators in the US, China and Japan gave a green ligh